In the latest trading session,, 9.43 million Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) shares changed hands as the company’s beta touched 4.20. With the company’s most recent per share price at $2.16 changing hands around $0.3 or 16.12% at last look, the market valuation stands at $4.95M. RDHL’s current price is a discount, trading about -838.43% off its 52-week high of $20.27. The share price had its 52-week low at $1.71, which suggests the last value was 20.83% up since then. When we look at Redhill Biopharma Ltd. ADR’s average trading volume, we note the 10-day average is 75180.0 shares, with the 3-month average coming to 102.36K.

Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) trade information

Instantly RDHL is in green as seen in intraday trades today. With action -0.92%, the performance over the past five days has been red. The company’s shares are showing year-to-date downside of -77.85%, with the 5-day performance at -0.92% in the red. However, in the 30-day time frame, Redhill Biopharma Ltd. ADR (NASDAQ:RDHL) is 17.39% up. Looking at the short shares, we see there were 63206.0 shares sold at short interest cover period of 0.33 days.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 65.76%.

RDHL Dividends

Redhill Biopharma Ltd. ADR is expected to release its next quarterly earnings report on 2024-May-31.

Redhill Biopharma Ltd. ADR (NASDAQ:RDHL)’s Major holders

The share float percentage for the stock currently stands at 5.67%.

With 41.0 shares estimated at $96.0 under it, the former controlled 0.00% of total outstanding shares.